Ruesch Center Symposium Focuses on Early-Onset GI Cancer
December 5th, 2023
John Marshall, MD, director of the Ruesch Center, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.…
FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC
December 5th, 2023
John L. Marshall, MD, sheds light on the significance of the FDA approval of fruquintinib for patients with heavily pretreated metastatic colorectal cancer and discusses the efficacy and safety data from the FRESCO and FRESCO-2 trials that supported the decision in this population.…
Luminary Awards Highlight Exemplary Work of Experts in GI Cancers
November 1st, 2023
The Luminary Awards in GI Cancers are designed to highlight the lifetime achievements of individuals who have dedicated their careers to expanding the knowledge of the GI cancer community.…
Mixed CRC Screening Messaging. Confusing? Some Docs Think So
November 1st, 2023
Dr. Marshall discusses updated colorectal cancer screening guidance from the American College of Physicians…
Dr. Marshall discusses updates for the management of patients with metastatic colorectal cancer
November 1st, 2023
Dr. Marshall joins experts for an overview on metastatic colorectal cancer, the latest advancements in treatments for metastatic colorectal cancer, and the future considerations for metastatic colorectal cancer.…
